KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Merck (MRK) over the last 16 years, with Q3 2025 value amounting to $45.0 million.

  • Merck's Short-term Investments changed N/A to $45.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.0 million, marking a year-over-year change of. This contributed to the annual value of $447.0 million for FY2024, which is 7738.1% up from last year.
  • Per Merck's latest filing, its Short-term Investments stood at $45.0 million for Q3 2025.
  • Merck's 5-year Short-term Investments high stood at $718.0 million for Q2 2023, and its period low was $40.0 million during Q1 2024.
  • For the 4-year period, Merck's Short-term Investments averaged around $360.0 million, with its median value being $409.5 million (2022).
  • Its Short-term Investments has fluctuated over the past 5 years, first plummeted by 9411.76% in 2024, then skyrocketed by 139750.0% in 2025.
  • Merck's Short-term Investments (Quarter) stood at $498.0 million in 2022, then crashed by 49.4% to $252.0 million in 2023, then soared by 77.38% to $447.0 million in 2024, then plummeted by 89.93% to $45.0 million in 2025.
  • Its Short-term Investments was $45.0 million in Q3 2025, compared to $615.0 million in Q2 2025 and $599.0 million in Q1 2025.